NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 4 filers reported holding NLS PHARMACEUTICS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $134,000 | – | 33,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 36,525 | $148,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 33,213 | $134,000 | 0.00% |
| Clearstead Advisors, LLC | 300 | $1,000 | 0.00% |